Literature DB >> 22270954

On the evidence for ESR1 amplification in breast cancer.

Frederik Holst, Cathy B Moelans, Martin Filipits, Christian F Singer, Ronald Simon, Paul J van Diest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22270954     DOI： 10.1038/nrc3093-c3

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  15 in total

1.  Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.

Authors:  Cathy B Moelans; Roel A de Weger; Hanneke N Monsuur; Raymon Vijzelaar; Paul J van Diest
Journal:  Mod Pathol       Date:  2010-05-14       Impact factor: 7.842

2.  Genetic heterogeneity in HER2 testing may influence therapy eligibility.

Authors:  Barbara Bernasconi; Anna Maria Chiaravalli; Giovanna Finzi; Katia Milani; Maria Grazia Tibiletti
Journal:  Breast Cancer Res Treat       Date:  2011-09-08       Impact factor: 4.872

3.  Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Authors:  B Ejlertsen; J Aldridge; K V Nielsen; M M Regan; K L Henriksen; A E Lykkesfeldt; S Müller; R D Gelber; K N Price; B B Rasmussen; G Viale; H Mouridsen
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

4.  Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.

Authors:  Kirsten Vang Nielsen; Bent Ejlertsen; Sven Müller; Susanne Møller; Birgitte B Rasmussen; Eva Balslev; Anne-Vibeke Lænkholm; Peer Christiansen; Henning T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  2010-06-17       Impact factor: 4.872

5.  ESR1 gene amplification: another mechanism regulating the cellular levels of ERα.

Authors:  Ke-Da Yu; Zhi-Ming Shao
Journal:  Nat Rev Cancer       Date:  2011-10-24       Impact factor: 60.716

Review 6.  The different roles of ER subtypes in cancer biology and therapy.

Authors:  Christoforos Thomas; Jan-Åke Gustafsson
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

7.  Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors.

Authors:  M Nembrot; B Quintana; J Mordoh
Journal:  Biochem Biophys Res Commun       Date:  1990-01-30       Impact factor: 3.575

8.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Authors:  Frederik Holst; Phillip R Stahl; Christian Ruiz; Olaf Hellwinkel; Zeenath Jehan; Marc Wendland; Annette Lebeau; Luigi Terracciano; Khawla Al-Kuraya; Fritz Jänicke; Guido Sauter; Ronald Simon
Journal:  Nat Genet       Date:  2007-04-08       Impact factor: 38.330

9.  Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.

Authors:  Cathy B Moelans; Roel A de Weger; Hanneke N Monsuur; Anoek H J Maes; Paul J van Diest
Journal:  Anal Cell Pathol (Amst)       Date:  2010       Impact factor: 2.916

10.  ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.

Authors:  Anita K Dunbier; Helen Anderson; Zara Ghazoui; Elena Lopez-Knowles; Sunil Pancholi; Ricardo Ribas; Suzanne Drury; Kally Sidhu; Alexandra Leary; Lesley-Ann Martin; Mitch Dowsett
Journal:  PLoS Genet       Date:  2011-04-28       Impact factor: 5.917
View more
  6 in total

Review 1.  Mechanisms of aromatase inhibitor resistance.

Authors:  Cynthia X Ma; Tomás Reinert; Izabela Chmielewska; Matthew J Ellis
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

Review 2.  Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Authors:  Frederik Holst
Journal:  World J Clin Oncol       Date:  2016-04-10

3.  Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification.

Authors:  Sanaz Tabarestani; Sayyed Mohammad Hossein Ghaderian; Hamid Rezvani; Reza Mirfakhraie; Abdolali Ebrahimi; Hamid Attarian; Jahangir Rafat; Mojtaba Ghadyani; Hossein Afshin Alavi; Naser Kamalian; Afshin Rakhsha; Eznollah Azargashb
Journal:  Cell Oncol (Dordr)       Date:  2014-02-27       Impact factor: 6.730

4.  Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.

Authors:  Anoek H J Verschuur-Maes; Cathy B Moelans; Peter C de Bruin; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2014-04-02       Impact factor: 6.730

5.  Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.

Authors:  Rachel E Bell; Tamar Golan; Danna Sheinboim; Hagar Malcov; David Amar; Avi Salamon; Tamar Liron; Sahar Gelfman; Yankel Gabet; Ron Shamir; Carmit Levy
Journal:  Genome Res       Date:  2016-02-23       Impact factor: 9.043

6.  ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.

Authors:  Cathy B Moelans; Frederik Holst; Olaf Hellwinkel; Ronald Simon; Paul J van Diest
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.